CompletedPhase 1

Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases

NCT03256344

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

University of California Los Angeles

Los Angeles, California, United States

+16 additional locations

Save this trial

University of California Los AngelesLos Angeles, California, United States
Columbia University Medical CenterNew York, New York, United States
Stony Brook UniversityStony Brook, New York, United States
Liverpool HospitalLiverpool, New South Wales, Australia
Monash Medical CentreClayton, Victoria, Australia
Fiona Stanley HospitalMurdoch, Western Australia, Australia
Breast Cancer Research Centre - WANedlands, Western Australia, Australia
Universite Catholique de Louvain Cliniques Universitaires Saint LucBrussels, Belgium
Universitair Ziekenhuis GentGhent, Belgium
UniversitÃ¤tsklinikum BonnBonn, Germany
UniversitÃ¤tsklinik TÃ¼bingenTÃ¼bingen, Germany
Hospital del MarBarcelona, CataluÃ±a, Spain
Hospital General Universitario Gregorio MaraÃ±onMadrid, Spain
Hospital Universitario Ramon y CajalMadrid, Spain
Inselspital BernBern, Switzerland
Hopitaux Universitaires de GeneveGeneva, Switzerland